National Specialist Testing
These specialist services are now live, and the laboratories will deliver services according to the National Genomic Test Directory
Specialist Genomic Tests
DPYD Testing in the North East and Yorkshire
Information & Referral Form
Accessing Genomic Testing Services During COVID-19
The Impact of Covid-19
During the current pandemic a number of changes to service have been implemented. For more information on the impact to testing, learn more in our Impact of COVID area.
Patients in England will soon get access to state of the art whole genome sequencing for a national set of rare inherited disorders and cancers. Documentation is available here.
A National Whole Genome Sequencing Service
Building a World Class Genomic Medicine Service
The NHS will be the world-leading healthcare system in its use of cutting edge genomic technologies to predict and diagnose inherited and acquired disease, and to personalise treatments and interventions.
Genomic Medicine Service
Consolidating and Enhancing the Existing Laboratory Provision
Genomic testing in the NHS is being provided through a single national testing network, consolidating and enhancing the existing laboratory provision.
Genomic Laboratory Hubs
In March 2017, the NHS England Board set out its strategic approach to build a National Genomic Medicine Service.
The UK is recognised internationally as a leader in genomics and the unique structure of the NHS supports the delivery of advances at scale and pace for patient benefit.
The National Genomic Medicine Service enables a quicker diagnosis for patients with a rare disease saving lives.
Matching people to the most effective medications and interventions, reducing the likelihood of an adverse drug reaction.
Increasing the number of people surviving cancer each year through accurate and early diagnosis, and effective use of personalised therapies.
“The NHS will be the world-leading healthcare system in its use of cutting edge genomic technologies to predict and diagnose inherited and acquired disease, and to personalise treatments and interventions.”